This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, X.
Right arrow Articles by Kappes, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, X.
Right arrow Articles by Kappes, J. C.

 Previous Article  |  Next Article 

Journal of Virology, March 1999, p. 2126-2135, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Human Immunodeficiency Virus Type 1 Integrase Protein Promotes Reverse Transcription through Specific Interactions with the Nucleoprotein Reverse Transcription Complex

Xiaoyun Wu,1 Hongmei Liu,1 Hongling Xiao,1 Joan A. Conway,1 Eric Hehl,2 Ganjam V. Kalpana,3 Vinayaka Prasad,2 and John C. Kappes1,4,5,*

Departments of Medicine1 and Microbiology,4 University of Alabama at Birmingham, Birmingham, Alabama 35294; Birmingham Veterans Affairs Medical Center Research Service, Birmingham, Alabama 352335; and Departments of Molecular Genetics3 and Microbiology and Immunology,2 Albert Einstein College of Medicine, Bronx, New York 10461

Received 21 August 1998/Accepted 20 November 1998

The human immunodeficiency virus type 1 (HIV-1) integrase protein (IN) is essential for integration of the viral DNA into host cell chromosomes. Since IN is expressed and assembled into virions as part of the 160-kDa Gag-Pol precursor polyprotein and catalyzes integration of the provirus in infected cells as a mature 32-kDa protein, mutations in IN are pleiotropic and may affect virus replication at different stages of the virus life cycle in addition to integration. Several different phenotypes have been observed for IN mutant viruses, including defects in virion morphology, protein composition, reverse transcription, nuclear import, and integration. Because the effects of mutations in the IN domain of Gag-Pol can not always be distinguished from those of mutations in the mature IN protein, there remains a significant gap in our understanding of IN function in vivo. To directly analyze the function of the mature IN protein itself, in the context of a replicating virus but independently from that of Gag-Pol, we used an approach developed in our laboratory for incorporating proteins into HIV virions by their expression in trans as fusion partners of either Vpr or Vpx. By providing IN in trans as a Vpr-IN fusion protein, our analysis revealed, for the first time, that the mature IN protein is essential for the efficient initiation of reverse transcription in infected cells and that this function does not require the IN protein to be enzymatically (integration) active. Our findings of a direct physical interaction between IN and reverse transcriptase and the failure of heterologous HIV-2 IN protein to efficiently support reverse transcription indicate that this novel function occurs through specific interactions with other viral components of the reverse transcription initiation complex. Studies involving complementation between integration- and DNA synthesis-defective IN mutants further support this conclusion and reveal that the highly conserved HHCC motif of IN is important for both activities. These findings provide important new insights into IN function and reverse transcription in the context of the nucleoprotein reverse transcription complex within the infected cell. Moreover, they validate a novel approach that obviates the need to mutate Gag-Pol in order to study the role of its individual mature components at the virus replication level.

* Corresponding author. Mailing address: University of Alabama at Birmingham, Department of Medicine, 1900 University Blvd., THT 513H, Birmingham, AL 35294. Phone: (205) 934-0051. Fax: (205) 975-7300. E-mail: KappesJC{at}uab.edu.

Journal of Virology, March 1999, p. 2126-2135, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Moore, S. P., Garfinkel, D. J. (2009). Functional Analysis of N-Terminal Residues of Ty1 Integrase. J. Virol. 83: 9502-9511 [Abstract] [Full Text]  
  • Woodward, C. L., Prakobwanakit, S., Mosessian, S., Chow, S. A. (2009). Integrase Interacts with Nucleoporin NUP153 To Mediate the Nuclear Import of Human Immunodeficiency Virus Type 1. J. Virol. 83: 6522-6533 [Abstract] [Full Text]  
  • Wilkinson, T. A., Januszyk, K., Phillips, M. L., Tekeste, S. S., Zhang, M., Miller, J. T., Le Grice, S. F. J., Clubb, R. T., Chow, S. A. (2009). Identifying and Characterizing a Functional HIV-1 Reverse Transcriptase-binding Site on Integrase. J. Biol. Chem. 284: 7931-7939 [Abstract] [Full Text]  
  • Chatterjee, A. G., Leem, Y. E., Kelly, F. D., Levin, H. L. (2009). The Chromodomain of Tf1 Integrase Promotes Binding to cDNA and Mediates Target Site Selection. J. Virol. 83: 2675-2685 [Abstract] [Full Text]  
  • Malet, I., Delelis, O., Valantin, M.-A., Montes, B., Soulie, C., Wirden, M., Tchertanov, L., Peytavin, G., Reynes, J., Mouscadet, J.-F., Katlama, C., Calvez, V., Marcelin, A.-G. (2008). Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro. Antimicrob. Agents Chemother. 52: 1351-1358 [Abstract] [Full Text]  
  • Dobard, C. W., Briones, M. S., Chow, S. A. (2007). Molecular Mechanisms by Which Human Immunodeficiency Virus Type 1 Integrase Stimulates the Early Steps of Reverse Transcription. J. Virol. 81: 10037-10046 [Abstract] [Full Text]  
  • Mousnier, A., Kubat, N., Massias-Simon, A., Segeral, E., Rain, J.-C., Benarous, R., Emiliani, S., Dargemont, C. (2007). von Hippel Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step. Proc. Natl. Acad. Sci. USA 104: 13615-13620 [Abstract] [Full Text]  
  • Liao, W.-H., Huang, K.-J., Chang, Y.-F., Wang, S.-M., Tseng, Y.-T., Chiang, C.-C., Wang, J.-J., Wang, C.-T. (2007). Incorporation of Human Immunodeficiency Virus Type 1 Reverse Transcriptase into Virus-Like Particles. J. Virol. 81: 5155-5165 [Abstract] [Full Text]  
  • Ao, Z., Huang, G., Yao, H., Xu, Z., Labine, M., Cochrane, A. W., Yao, X. (2007). Interaction of Human Immunodeficiency Virus Type 1 Integrase with Cellular Nuclear Import Receptor Importin 7 and Its Impact on Viral Replication. J. Biol. Chem. 282: 13456-13467 [Abstract] [Full Text]  
  • Puglia, J., Wang, T., Smith-Snyder, C., Cote, M., Scher, M., Pelletier, J. N., John, S., Jonsson, C. B., Roth, M. J. (2006). Revealing Domain Structure through Linker-Scanning Analysis of the Murine Leukemia Virus (MuLV) RNase H and MuLV and Human Immunodeficiency Virus Type 1 Integrase Proteins. J. Virol. 80: 9497-9510 [Abstract] [Full Text]  
  • Wilhelm, M., Wilhelm, F.-X. (2006). Cooperation between Reverse Transcriptase and Integrase during Reverse Transcription and Formation of the Preintegrative Complex of Ty1.. Eukaryot Cell 5: 1760-1769 [Abstract] [Full Text]  
  • Atwood-Moore, A., Yan, K., Judson, R. L., Levin, H. L. (2006). The Self Primer of the Long Terminal Repeat Retrotransposon Tf1 Is Not Removed during Reverse Transcription.. J. Virol. 80: 8267-8270 [Abstract] [Full Text]  
  • Hamamoto, S., Nishitsuji, H., Amagasa, T., Kannagi, M., Masuda, T. (2006). Identification of a Novel Human Immunodeficiency Virus Type 1 Integrase Interactor, Gemin2, That Facilitates Efficient Viral cDNA Synthesis In Vivo.. J. Virol. 80: 5670-5677 [Abstract] [Full Text]  
  • Mulky, A., Kappes, J. C. (2005). Analysis of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Subunit Structure/Function in the Context of Infectious Virions and Human Target Cells. Antimicrob. Agents Chemother. 49: 3762-3769 [Abstract] [Full Text]  
  • Wapling, J., Moore, K. L., Sonza, S., Mak, J., Tachedjian, G. (2005). Mutations That Abrogate Human Immunodeficiency Virus Type 1 Reverse Transcriptase Dimerization Affect Maturation of the Reverse Transcriptase Heterodimer. J. Virol. 79: 10247-10257 [Abstract] [Full Text]  
  • Oz Gleenberg, I., Avidan, O., Goldgur, Y., Herschhorn, A., Hizi, A. (2005). Peptides Derived from the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 as Novel Inhibitors of the Viral Integrase. J. Biol. Chem. 280: 21987-21996 [Abstract] [Full Text]  
  • Wilhelm, M., Wilhelm, F.-X. (2005). Role of Integrase in Reverse Transcription of the Saccharomyces cerevisiae Retrotransposon Ty1. Eukaryot Cell 4: 1057-1065 [Abstract] [Full Text]  
  • Buxton, P., Tachedjian, G., Mak, J. (2005). Analysis of the Contribution of Reverse Transcriptase and Integrase Proteins to Retroviral RNA Dimer Conformation. J. Virol. 79: 6338-6348 [Abstract] [Full Text]  
  • Lu, R., Limon, A., Devroe, E., Silver, P. A., Cherepanov, P., Engelman, A. (2004). Class II Integrase Mutants with Changes in Putative Nuclear Localization Signals Are Primarily Blocked at a Postnuclear Entry Step of Human Immunodeficiency Virus Type 1 Replication. J. Virol. 78: 12735-12746 [Abstract] [Full Text]  
  • Cherepanov, P., Devroe, E., Silver, P. A., Engelman, A. (2004). Identification of an Evolutionarily Conserved Domain in Human Lens Epithelium-derived Growth Factor/Transcriptional Co-activator p75 (LEDGF/p75) That Binds HIV-1 Integrase. J. Biol. Chem. 279: 48883-48892 [Abstract] [Full Text]  
  • Mulky, A., Sarafianos, S. G., Arnold, E., Wu, X., Kappes, J. C. (2004). Subunit-Specific Analysis of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase In Vivo. J. Virol. 78: 7089-7096 [Abstract] [Full Text]  
  • Parveen, Z., Mukhtar, M., Goodrich, A., Acheampong, E., Dornburg, R., Pomerantz, R. J. (2004). Cross-Packaging of Human Immunodeficiency Virus Type 1 Vector RNA by Spleen Necrosis Virus Proteins: Construction of a New Generation of Spleen Necrosis Virus-Derived Retroviral Vectors. J. Virol. 78: 6480-6488 [Abstract] [Full Text]  
  • Bonnenfant, S., Thomas, C. M., Vita, C., Subra, F., Deprez, E., Zouhiri, F., Desmaele, D., d'Angelo, J., Mouscadet, J. F., Leh, H. (2004). Styrylquinolines, Integrase Inhibitors Acting Prior to Integration: a New Mechanism of Action for Anti-Integrase Agents. J. Virol. 78: 5728-5736 [Abstract] [Full Text]  
  • Zhu, K., Dobard, C., Chow, S. A. (2004). Requirement for Integrase during Reverse Transcription of Human Immunodeficiency Virus Type 1 and the Effect of Cysteine Mutations of Integrase on Its Interactions with Reverse Transcriptase. J. Virol. 78: 5045-5055 [Abstract] [Full Text]  
  • Hehl, E. A., Joshi, P., Kalpana, G. V., Prasad, V. R. (2004). Interaction between Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Integrase Proteins. J. Virol. 78: 5056-5067 [Abstract] [Full Text]  
  • Yung, E., Sorin, M., Wang, E.-J., Perumal, S., Ott, D., Kalpana, G. V. (2004). Specificity of Interaction of INI1/hSNF5 with Retroviral Integrases and Its Functional Significance. J. Virol. 78: 2222-2231 [Abstract] [Full Text]  
  • Padow, M., Lai, L., Deivanayagam, C., DeLucas, L. J., Weiss, R. B., Dunn, D. M., Wu, X., Kappes, J. C. (2003). Replication of Chimeric Human Immunodeficiency Virus Type 1 (HIV-1) Containing HIV-2 Integrase (IN): Naturally Selected Mutations in IN Augment DNA Synthesis. J. Virol. 77: 11050-11059 [Abstract] [Full Text]  
  • Khiytani, D. K., Dimmock, N. J. (2002). Characterization of a human immunodeficiency virus type 1 pre-integration complex in which the majority of the cDNA is resistant to DNase I digestion. J. Gen. Virol. 83: 2523-2532 [Abstract] [Full Text]  
  • Mulder, L. C. F., Chakrabarti, L. A., Muesing, M. A. (2002). Interaction of HIV-1 Integrase with DNA Repair Protein hRad18. J. Biol. Chem. 277: 27489-27493 [Abstract] [Full Text]  
  • Werner, S., Hindmarsh, P., Napirei, M., Vogel-Bachmayr, K., Wohrl, B. M. (2002). Subcellular Localization and Integration Activities of Rous Sarcoma Virus Reverse Transcriptase. J. Virol. 76: 6205-6212 [Abstract] [Full Text]  
  • Shehu-Xhilaga, M., Hill, M., Marshall, J. A., Kappes, J., Crowe, S. M., Mak, J. (2002). The Conformation of the Mature Dimeric Human Immunodeficiency Virus Type 1 RNA Genome Requires Packaging of Pol Protein. J. Virol. 76: 4331-4340 [Abstract] [Full Text]  
  • Nymark-McMahon, M. H., Beliakova-Bethell, N. S., Darlix, J.-L., Le Grice, S. F. J., Sandmeyer, S. B. (2002). Ty3 Integrase Is Required for Initiation of Reverse Transcription. J. Virol. 76: 2804-2816 [Abstract] [Full Text]  
  • Lai, L., Liu, H., Wu, X., Kappes, J. C. (2001). Moloney Murine Leukemia Virus Integrase Protein Augments Viral DNA Synthesis in Infected Cells. J. Virol. 75: 11365-11372 [Abstract] [Full Text]  
  • Jenkins, Y., Pornillos, O., Rich, R. L., Myszka, D. G., Sundquist, W. I., Malim, M. H. (2001). Biochemical Analyses of the Interactions between Human Immunodeficiency Virus Type 1 Vpr and p6Gag. J. Virol. 75: 10537-10542 [Abstract] [Full Text]  
  • Tang, S., Murakami, T., Agresta, B. E., Campbell, S., Freed, E. O., Levin, J. G. (2001). Human Immunodeficiency Virus Type 1 N-Terminal Capsid Mutants That Exhibit Aberrant Core Morphology and Are Blocked in Initiation of Reverse Transcription in Infected Cells. J. Virol. 75: 9357-9366 [Abstract] [Full Text]  
  • Hooker, C. W., Lott, W. B., Harrich, D. (2001). Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Target Distinct Phases of Early Reverse Transcription. J. Virol. 75: 3095-3104 [Abstract] [Full Text]  
  • Hameau, L., Jeusset, J., Lafosse, S., Coulaud, D., Delain, E., Unge, T., Restle, T., Le Cam, E., Mirambeau, G. (2001). Human Immunodeficiency Virus Type 1 Central DNA Flap: Dynamic Terminal Product of Plus-Strand Displacement DNA Synthesis Catalyzed by Reverse Transcriptase Assisted by Nucleocapsid Protein. J. Virol. 75: 3301-3313 [Abstract] [Full Text]  
  • Holmes-Son, M. L., Chow, S. A. (2000). Integrase-LexA Fusion Proteins Incorporated into Human Immunodeficiency Virus Type 1 That Contains a Catalytically Inactive Integrase Gene Are Functional To Mediate Integration. J. Virol. 74: 11548-11556 [Abstract] [Full Text]  
  • Petit, C., Schwartz, O., Mammano, F. (2000). The Karyophilic Properties of Human Immunodeficiency Virus Type 1 Integrase Are Not Required for Nuclear Import of Proviral DNA. J. Virol. 74: 7119-7126 [Abstract] [Full Text]  
  • Liu, H., Wu, X., Xiao, H., Kappes, J. C. (1999). Targeting Human Immunodeficiency Virus (HIV) Type 2 Integrase Protein into HIV Type 1. J. Virol. 73: 8831-8836 [Abstract] [Full Text]  
  • Baldwin, D. N., Linial, M. L. (1999). Proteolytic Activity, the Carboxy Terminus of Gag, and the Primer Binding Site Are Not Required for Pol Incorporation into Foamy Virus Particles. J. Virol. 73: 6387-6393 [Abstract] [Full Text]  
  • Chen, H., Wei, S.-Q., Engelman, A. (1999). Multiple Integrase Functions Are Required to Form the Native Structure of the Human Immunodeficiency Virus Type I Intasome. J. Biol. Chem. 274: 17358-17364 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»